Folate (B9, folic acid / 5-MTHF)
Guidelines advise a daily folic acid supplement from before conception through early pregnancy to reduce neural tube defect risk, backed by a randomised trial.
- Evidence
- Strong evidenceGRADE certainty: High
- Typical dose
- 400 µg/day folic acid
- Time to effect
- Red-cell folate rises over 8–12 weeks
- Safety
- Has documented cautions
Evidence ratings summarise published research on Folate (B9, folic acid / 5-MTHF) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Folate (B9, folic acid / 5-MTHF)
Interactions
Taking any medication?
Check Folate (B9, folic acid / 5-MTHF) against it.
Why
The MRC Vitamin Study 1991 (Lancet) randomised 1,817 women with a previous neural tube defect pregnancy: 6 neural tube defects occurred with periconceptional folic acid versus 21 without. The USPSTF (grade A, high certainty of substantial net benefit), WHO and NICE advise a daily folic acid supplement for everyone planning or able to become pregnant, from before conception through the first trimester, with higher doses for those at increased risk.
How it works
One-carbon donor for DNA synthesis (thymidylate, purines) and methylation (via 5-methyltetrahydrofolate → methionine → SAM). 5-MTHF is the active form delivered to tissues; folic acid is reduced through DHFR before use.
Expected onset · Red-cell folate rises over 8–12 weeks; guidelines advise starting before conception
How to take
Dosage
400 µg/day folic acid (EU-authorised dose for NTD risk reduction). 4–5 mg/day for women with a previous NTD-affected pregnancy (the MRC trial dose), only under medical supervision. 5-MTHF (methylfolate) is an alternative for those who prefer the active form, dosed equivalently.
Timing
Daily, ideally from ≥1 month preconception through the first trimester
On the label
Both folic acid and 5-MTHF deliver the protective effect at 400 µg. Avoid combined products with ≥1 mg folic acid unless prescribed.
Studied in
Anyone planning a pregnancy or able to become pregnant; people with known MTHFR variants or elevated homocysteine; long-term users of methotrexate, sulfasalazine, or anticonvulsants under clinician supervision.
Safety
Evidence
USPSTF guideline (2023) recommends, with high certainty of substantial net benefit (grade A), that everyone planning or able to become pregnant take a daily folic acid supplement from before conception through the first trimester; WHO and NICE advise the same, with higher doses for those at increased risk. MRC Vitamin Study 1991 Lancet RCT (n=1,817 women with a previous affected pregnancy) recorded 6 neural tube defects with folic acid versus 21 without.
GRADE certainty: High — reported by USPSTF 2023 (high certainty of substantial net benefit)
- MRC Vitamin Study Research Group, Lancet 1991 (n=1,817), periconceptional folic acid cut NTD recurrence 72%
- USPSTF guideline (2023): Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication (2023 reaffirmation)
- WHO guideline (2022): Periconceptional folic acid supplementation to prevent neural tube defects (ELENA guideline)
- NICE guideline (2023): Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years (NG247)
Questions people ask
Does Folate (B9, folic acid / 5-MTHF) work?
USPSTF guideline (2023) recommends, with high certainty of substantial net benefit (grade A), that everyone planning or able to become pregnant take a daily folic acid supplement from before conception through the first trimester; WHO and NICE advise the same, with higher doses for those at increased risk. MRC Vitamin Study 1991 Lancet RCT (n=1,817 women with a previous affected pregnancy) recorded 6 neural tube defects with folic acid versus 21 without. Certainty of the evidence: High, reported by USPSTF 2023 (high certainty of substantial net benefit).
How is Folate (B9, folic acid / 5-MTHF) taken?
400 µg/day folic acid (EU-authorised dose for NTD risk reduction). 4–5 mg/day for women with a previous NTD-affected pregnancy (the MRC trial dose), only under medical supervision. 5-MTHF (methylfolate) is an alternative for those who prefer the active form, dosed equivalently. Timing: Daily, ideally from ≥1 month preconception through the first trimester. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Can mask vitamin B12 deficiency on bloodwork, check B12 status before high-dose folate, especially in older adults. Discuss with a doctor before high doses with epilepsy, methotrexate, or a personal history of folate-sensitive cancers. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: MRC Vitamin Study Research Group, Lancet 1991 (n=1,817), periconceptional folic acid cut NTD recurrence 72%; USPSTF guideline (2023): Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication (2023 reaffirmation); WHO guideline (2022): Periconceptional folic acid supplementation to prevent neural tube defects (ELENA guideline); NICE guideline (2023): Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years (NG247).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.